| Ticker | Report or Guide | KPI | Prediction | Answer | Confidence |
|---|---|---|---|---|---|
| CVS | Return | Day-1 residual (stock − beta × S&P 500) | +9.8% | — | LOW |
| CVS | Return | 5-day cumulative residual | +3.2% (FADE) | Beat-and-raise is largely priced (CVS +30% YTD, off its ~5% from July $110 peak into print). Positive day-1 pop on clean adj-EPS/MBR beat plus a guidance raise-to-high-end/modest lift. But the 60/40 front-loaded shape means the H2 implied run-rate stays soft — a modest raise mathematically trims out-quarter estimates, and any 'low-quality' PYD-driven beat plus a stretched multiple caps follow-through, so early gains partially fade. | LOW |